UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): April 23, 2010
CPEX Pharmaceuticals, Inc.
(Exact name of registrant as specified in its charter)
DELAWARE
(State or other jurisdiction of incorporation)
| | | |
|
| 1-33895 | | 26-1172076 |
| | | |
| (Commission file number) | | (IRS Employer Identification Number) |
| | | |
|
| 2 Holland Way, Exeter, New Hampshire | | 03833 |
| | | |
| (Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code: (603) 658-6100
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Other Events.
On April 23, 2010 CPEX Pharmaceuticals, Inc. issued a press release in response to the tender offer documents filed by Arcadia Capital Advisors, LLC through Shelter Bay Holdings, LLC, a New York limited liability company, and RSR Acquisition Company. A copy of this press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d)Exhibits
| | | |
| Exhibit | | |
| Number | | Description |
| 99.1 | | Press Release dated April 23, 2010. |
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | |
| | CPEX PHARMACEUTICALS, INC.
Registrant
| |
| | By: | /s/ Robert P. Hebert | |
| | | Robert P. Hebert | |
| | | Vice President and Chief Financial Officer | |
| |
Dated: April 23, 2010
Index to Exhibits
| | | |
| Exhibit | | |
| Number | | Description |
| 99.1 | | Press Release dated April 23, 2010. |
